Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition

Cell Cycle

Volumn 13, Issue 5, 2014, Pages 845-858

  Jones, Tiffany ^a,b   Da Silva, Suzane Ramos ^b   Bedolla, Roble ^a   Ye, Fengchun ^a,c   Zhou, Fuchun ^a   Gao, Shou Jiang ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cell cycle progression; Cell proliferation; Cellular transformation; Contact inhibition; Kaposi sarcoma; KSHV; p27 Kip1; Tumorigenesis; vCyclin ORF72

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27; SERINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRAL CYCLIN; VIRUS ANTIGEN; CYCLIN D2; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DENSITY; CELL MUTANT; CELL PROLIFERATION; CELL SURVIVAL; CONTACT INHIBITION; CONTROLLED STUDY; DELETION MUTANT; HOMOLOGOUS RECOMBINATION; HUMAN HERPESVIRUS 8; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; VIRUS CELL TRANSFORMATION; VIRUS RECOMBINANT; ANIMAL; CELL AGING; CELL CYCLE; CELL TRANSFORMATION; GENETICS; METABOLISM; MUTATION; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL AGING; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CONTACT INHIBITION; CYCLIN D2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HERPESVIRUS 8, HUMAN; MICE, NUDE; MUTATION; PHOSPHORYLATION; VIRAL PROTEINS;

EID: 84897980090     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.27758     Document Type: Article

References (50)

1. Greene W, Kuhne K, Ye F, Chen J, Zhou F, Lei X, Gao SJ. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 2007; 133:69-127; PMID:17672038; http://dx.doi.org/10.1007/978-0-387-46816-7-3
2. Jones T, Ye F, Bedolla R, Huang Y, Meng J, Qian L, Pan H, Zhou F, Moody R, Wagner B, et al. Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. J Clin Invest 2012; 122:1076-81; PMID:22293176; http://dx.doi.org/10.1172/JCI58530
3. Ye F, Lei X, Gao SJ. Mechanisms of Kaposi Sarcoma- Associated Herpesvirus Latency and Reactivation. Adv Virol 2011; 2011; PMID:21625290; http://dx.doi.org/10.1155/2011/193860
4. Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog 2013; 9:e1003857; PMID:24385912; http://dx.doi.org/10.1371/journal.ppat.1003857
5. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden-Kent, Paterson H, Weiss RA, Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 1996; 382:410; PMID:8684480; http://dx.doi.org/10.1038/382410a0
6. Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F, Jung JU. Kaposi sarcoma-associated herpesvirus encodes a functional Cyclin. J Virol 1997; 71:1984-91; PMID:9032330
7. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. The Cyclin encoded by Kaposi sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997; 71:4193-8; PMID:9151805
8. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral Cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390:184-7; PMID:9367157; http://dx.doi.org/10.1038/36606
9. Chang PC, Li M. Kaposi sarcoma-associated herpesvirus K-Cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor. J Virol 2008; 82:278-90; PMID:17942552; http://dx.doi.org/10.1128/JVI.01552-07
10. Child ES, Mann DJ. Novel properties of the Cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene 2001; 20:3311-22; PMID:11423981; http://dx.doi.org/10.1038/sj.onc.1204447
11. Järviluoma A, Koopal S, Räsänen S, Mäkelä TP, Ojala PM. KSHV viral Cyclin binds to p27KIP1 in primary effusion lymphomas. Blood 2004; 104:3349-54; PMID:15271792; http://dx.doi.org/10.1182/blood-2004-05- 1798
12. Ojala PM, Yamamoto K, Castaños-Vélez E, Biberfeld P, Korsmeyer SJ, Mäkelä TP. The apoptotic v-Cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000; 2:819-25; PMID:11056537; http://dx.doi.org/10.1038/35041064
13. Laman H, Coverley D, Krude T, Laskey R, Jones N. Viral Cyclin-Cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol Cell Biol 2001; 21:624-35; PMID:11134348; http://dx.doi.org/10.1128/MCB.21.2. 624-635.2001
14. Sarek G, Järviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM. Nucleophosmin phosphorylation by v-Cyclin-CDK6 controls KSHV latency. PLoS Pathog 2010; 6:e1000818; PMID:20333249; http://dx.doi.org/10. 1371/journal.ppat.1000818
15. Järviluoma A, Child ES, Sarek G, Sirimongkolkasem P, Peters G, Ojala PM, Mann DJ. Phosphorylation of the Cyclin-dependent kinase inhibitor p21Cip1 on serine 130 is essential for viral Cyclin-mediated bypass of a p21Cip1-imposed G1 arrest. Mol Cell Biol 2006; 26:2430-40; PMID:16508017; http://dx.doi.org/10. 1128/MCB.26.6.2430-2440.2006
16. Sarek G, Järviluoma A, Ojala PM. KSHV viral Cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 2006; 107:725-32; PMID:16160006; http://dx.doi.org/10. 1182/blood-2005-06-2534
17. Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA, Lu X, Mittnacht S. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi sarcoma virus Cyclin-cdk6 complex. EMBO J 1999; 18:644-53; PMID:9927424; http://dx.doi.org/10.1093/emboj/18.3.644
18. Mann DJ, Child ES, Swanton C, Laman H, Jones N. Modulation of p27(Kip1) levels by the Cyclin encoded by Kaposi sarcoma-associated herpesvirus. EMBO J 1999; 18:654-63; PMID:9927425; http://dx.doi.org/10.1093/emboj/18.3.654
19. Verschuren EW, Klefstrom J, Evan GI, Jones N. The oncogenic potential of Kaposi sarcoma-associated herpesvirus Cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2002; 2:229-41; PMID:12242155; http://dx.doi.org/10.1016/ S1535-6108(02)00123-X
20. Kaldis P. The N-terminal peptide of the Kaposi sarcoma-associated herpesvirus (KSHV)-Cyclin determines substrate specificity. J Biol Chem 2005; 280:11165-74; PMID:15664993; http://dx.doi.org/10.1074/jbc.M408887200
21. Kaldis P, Ojala PM, Tong L, Mäkelä TP, Solomon MJ. CAK-independent activation of CDK6 by a viral Cyclin. Mol Biol Cell 2001; 12:3987-99; PMID:11739795; http://dx.doi.org/10.1091/mbc.12.12.3987
22. Yoshioka H, Noguchi K, Katayama K, Mitsuhashi J, Yamagoe S, Fujimuro M, Sugimoto Y. Functional availability of gamma-herpesvirus K-Cyclin is regulated by cellular CDK6 and p16INK4a. Biochem Biophys Res Commun 2010; 394:1000-5; PMID:20331971; http://dx.doi.org/10.1016/j.bbrc.2010.03.110
23. Verschuren EW, Hodgson JG, Gray JW, Kogan S, Jones N, Evan GI. The role of p53 in suppression of KSHV Cyclin-induced lymphomagenesis. Cancer Res 2004; 64:581-9; PMID:14744772; http://dx.doi.org/10.1158/0008-5472.CAN-03-1863
24. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. Efficient infection by a recombinant Kaposi sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 2002; 76:6185-96; PMID:12021352; http://dx.doi.org/10.1128/JVI.76.12.6185-6196.2002
25. Koopal S, Furuhjelm JH, Järviluoma A, Jäämaa S, Pyakurel P, Pussinen C, Wirzenius M, Biberfeld P, Alitalo K, Laiho M, et al. Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 2007; 3:1348-60; PMID:17907806; http://dx.doi.org/10. 1371/journal.ppat.0030140
26. Starostina NG, Kipreos ET. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 2012; 22:33-41; PMID:22154077; http://dx.doi.org/10.1016/j.tcb.2011.10.004
27. Ishida N, Kitagawa M, Hatakeyama S, Nakayama K. Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J Biol Chem 2000; 275:25146-54; PMID:10831586; http://dx.doi.org/10.1074/jbc. M001144200
28. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661-4; PMID:10375532; http://dx.doi.org/10.1016/ S0960-9822(99)80290-5
29. Leidal AM, Cyr DP, Hill RJ, Lee PW, McCormick C. Subversion of autophagy by Kaposi sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell Host Microbe 2012; 11:167-80; PMID:22341465; http://dx.doi.org/10.1016/j. chom.2012.01.005
30. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
31. Zhang X, Wharton W, Donovan M, Coppola D, Croxton R, Cress WD, Pledger WJ. Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol Biol Cell 2000; 11:2117-30; PMID:10848633; http://dx.doi.org/10. 1091/mbc.11.6.2117
32. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J. Cloning of p27Kip1, a Cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66; PMID:8033212; http://dx.doi.org/10.1016/0092-8674(94)90572-X
33. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 2002; 277:14355-8; PMID:11889117; http://dx.doi.org/10.1074/jbc.C100762200
34. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. A growth factordependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J 2002; 21:3390-401; PMID:12093740; http://dx.doi.org/10.1093/emboj/cdf343
35. Ojala PM, Tiainen M, Salven P, Veikkola T, Castaños-Vélez E, Sarid R, Biberfeld P, Mäkelä TP. Kaposi sarcoma-associated herpesvirus-encoded v-Cyclin triggers apoptosis in cells with high levels of Cyclin-dependent kinase 6. Cancer Res 1999; 59:4984-9; PMID:10519412
36. Abend JR, Uldrick T, Ziegelbauer JM. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J Virol 2010; 84:12139-51; PMID:20844036; http://dx.doi.org/10.1128/JVI.00884-10
37. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, Richardson JA, Smith AL, Chaudhary PM. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci U S A 2005; 102:12885-90; PMID:16120683; http://dx.doi.org/10.1073/pnas.0408577102
38. Fakhari FD, Jeong JH, Kanan Y, Dittmer DP. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Invest 2006; 116:735-42; PMID:16498502; http://dx.doi.org/10. 1172/JCI26190
39. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007; 450:1096-9; PMID:18075594; http://dx.doi.org/10.1038/nature05992
40. Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 2010; 12:193-9; PMID:20081837; http://dx.doi.org/10.1038/ncb2019
41. Lei X, Zhu Y, Jones T, Bai Z, Huang Y, Gao SJ. A Kaposi sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival. J Virol 2012; 86:11698-711; PMID:22915806; http://dx.doi.org/10.1128/JVI.06855-11
42. Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000; 6:1121-7; PMID:11017143; http://dx.doi.org/10.1038/80459
43. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. Kaposi sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 2007; 81:12836-45; PMID:17881434; http://dx.doi.org/10.1128/JVI.01804-07
44. Suffert G, Malterer G, Hausser J, Viiliäinen J, Fender A, Contrant M, Ivacevic T, Benes V, Gros F, Voinnet O, et al. Kaposi sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog 2011; 7:e1002405; PMID:22174674; http://dx.doi.org/10.1371/journal.ppat.1002405
45. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000; 97:6640-5; PMID:10829079; http://dx.doi.org/10.1073/pnas.120163297
46. Li Q, Zhou F, Ye F, Gao SJ. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 2008; 379:234-44; PMID:18684478; http://dx.doi.org/10.1016/j.virol.2008.06.043
47. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, et al. Seroconversion to antibodies against Kaposi sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi sarcoma. N Engl J Med 1996; 335:233-41; PMID:8657239; http://dx.doi.org/10.1056/NEJM199607253350403
48. Greene W, Zhang W, He M, Witt C, Ye F, Gao SJ. The ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi sarcoma-associated herpesvirus in endothelial cells. PLoS Pathog 2012; 8:e1002703; PMID:22615563; http://dx.doi.org/10.1371/journal.ppat.1002703
49. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/10.1073/pnas.92.20.9363
50. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997; 15:1979-85; PMID:9365244; http://dx.doi.org/10.1038/sj.onc. 1201571